Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
Tourjman SV, Buck G, Jutras-Aswad D, Khullar A, McInerney S, Saraf G, Pinto JV, Potvin S, Poulin MJ, Frey BN, Kennedy SH, Lam RW, MacQueen G, Milev R, Parikh SV, Ravindran A, McIntyre RS, Schaffer A, Taylor VH, van Ameringen M, Yatham LN, Beaulieu S.
Can J Psychiatry. 2023 May;68(5):299-311. doi: 10.1177/07067437221099769. Epub 2022 Jun 16.
Status of Type II vs. Type I Bipolar Disorder: Systematic Review with Meta-Analyses.
Hernandorena CV, Baldessarini RJ, Tondo L, Vázquez GH.
Harv Rev Psychiatry. 2023 Jul-Aug 01;31(4):173-182. doi: 10.1097/HRP.0000000000000371.
Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials.
Nestsiarovich A, Gaudiot CES, Baldessarini RJ, Vieta E, Zhu Y, Tohen M.
Eur Neuropsychopharmacol. 2022 Jan;54:75-89. doi: 10.1016/j.euroneuro.2021.08.264. Epub 2021 Sep 3.
Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.
Hinkle JT, Graziosi M, Nayak SM, Yaden DB.
JAMA Psychiatry. 2024 Dec 1;81(12):1225-1235. doi: 10.1001/jamapsychiatry.2024.2546.
Topiramate-Induced Lithium Toxicity.
Khan AH, Shah SQ.
Cureus. 2017 Oct 26;9(10):e1804. doi: 10.7759/cureus.1804.
No Little Feet: Managing Pseudocyesis in a Homeless, Acutely Manic Patient with Schizoaffective Disorder, Bipolar Type.
West T, Ajibade O, Fontanetta A, Munir S.
Case Rep Psychiatry. 2023 Dec 13;2023:2504871. doi: 10.1155/2023/2504871. eCollection 2023.
What we know and what we don't know about the treatment of schizoaffective disorder.
Murru A, Pacchiarotti I, Nivoli AM, Grande I, Colom F, Vieta E.
Eur Neuropsychopharmacol. 2011 Sep;21(9):680-90. doi: 10.1016/j.euroneuro.2011.03.001. Epub 2011 May 12.
Cariprazine-induced mania: A case series report.
Pons-Cabrera MT, Palacios-Garrán R, Tardón-Senabre L, Fernández-Plaza T, Marco-Estrada O, Madero S, Anmella G, Colomer L, Druetta M, Giménez-Palomo A, Navarro-Cortés L, Sagué-Vilavella M, Sánchez-Sierra C, Verdolini N, Catalan R, Bioque M, Goikolea JM, Vieta E, Pacchiarotti I.
Bipolar Disord. 2022 Jun;24(4):457-460. doi: 10.1111/bdi.13156. Epub 2021 Nov 27.
Treatment adherence in bipolar I and schizoaffective disorder, bipolar type.
Murru A, Pacchiarotti I, Amann BL, Nivoli AM, Vieta E, Colom F.
J Affect Disord. 2013 Dec;151(3):1003-8. doi: 10.1016/j.jad.2013.08.026. Epub 2013 Sep 3.
Olanzapine versus haloperidol in schizoaffective disorder, bipolar type.
Tohen M, Zhang F, Keck PE, Feldman PD, Risser RC, Tran PV, Breier A.
J Affect Disord. 2001 Dec;67(1-3):133-40. doi: 10.1016/s0165-0327(00)00303-7.
